Skip to main content
. 2015 Oct 8;8:105–114. doi: 10.2147/JAA.S40244

Figure 1.

Figure 1

Interaction between Th2 lymphocytes and eosinophils, and molecular structure of mepolizumab with its therapeutic target.

Abbreviation: IL, interleukin.